Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]pip eridine compounds

Details for Australian Patent Application No. 2009313948 (hide)

Owner Theravance, Inc.

Inventors Stangeland, Eric L.; Rapta, Miroslav

Agent Davies Collison Cave

Pub. Number AU-A-2009313948

PCT Pub. Number WO2010/056938

Priority 61/114,541 14.11.08 US

Filing date 13 November 2009

Wipo publication date 20 May 2010

International Classifications

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/056938 Priority application(s): WO2010/056938

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313949-Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]pip eridine compound

2009313937-Chitosan derivatives alone or in combination for the treatment of MDR microbial infections